Terms: = Brain cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1 AND Prognosis
17 results:
1. LncRNA GAS5 Regulates Gemcitabine Resistance in Pancreatic Carcinoma by Targeting miRNA-21.
Huang K; Yang G
Ann Clin Lab Sci; 2023 Mar; 53(2):222-229. PubMed ID: 37094852
[TBL] [Abstract] [Full Text] [Related]
2. cancer Stem Cell and Aggressiveness Traits Are Promoted by Stable Endothelin-Converting Enzyme-1c in Glioblastoma Cells.
Niechi I; Erices JI; Carrillo-Beltrán D; Uribe-Ojeda A; Torres Á; Rocha JD; Uribe D; Toro MA; Villalobos-Nova K; Gaete-Ramírez B; Mingo G; Owen GI; Varas-Godoy M; Jara L; Aguayo F; Burzio VA; Quezada-Monrás C; Tapia JC
Cells; 2023 Feb; 12(3):. PubMed ID: 36766848
[TBL] [Abstract] [Full Text] [Related]
3. Differences of macrophages in the tumor microenvironment as an underlying key factor in glioma patients.
Wang Y; Liu Y; Zhang C; Zhang C; Guan X; Jia W
Front Immunol; 2022; 13():1028937. PubMed ID: 36389681
[TBL] [Abstract] [Full Text] [Related]
4. Expression of ABCB1, ABCC1 and 3 and abcg2 in glioblastoma and their relevance in relation to clinical survival surrogates.
Roy LO; Lemelin M; Blanchette M; Poirier MB; Aldakhil S; Fortin D
J Neurooncol; 2022 Dec; 160(3):601-609. PubMed ID: 36342588
[TBL] [Abstract] [Full Text] [Related]
5. CRISPR/Cas9-induced knockout reveals the role of ABCB1 in the response to temozolomide, carmustine and lomustine in glioblastoma multiforme.
Radtke L; Majchrzak-Celińska A; Awortwe C; Vater I; Nagel I; Sebens S; Cascorbi I; Kaehler M
Pharmacol Res; 2022 Nov; 185():106510. PubMed ID: 36252775
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of Factors Affecting 5-ALA Fluorescence Intensity in Visualizing Glial Tumor Cells-Literature Review.
Mazurek M; Szczepanek D; Orzyłowska A; Rola R
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055109
[TBL] [Abstract] [Full Text] [Related]
7. Immunohistochemical Analysis of DNA Repair- and Drug-Efflux-Associated Molecules in Tumor and Peritumor Areas of Glioblastoma.
Angelucci C; D'Alessio A; Sorrentino S; Biamonte F; Moscato U; Mangiola A; Sica G; Iacopino F
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562724
[TBL] [Abstract] [Full Text] [Related]
8. Blood-brain barrier disruption with low-intensity pulsed ultrasound for the treatment of pediatric brain tumors: a review and perspectives.
Beccaria K; Canney M; Bouchoux G; Puget S; Grill J; Carpentier A
Neurosurg Focus; 2020 Jan; 48(1):E10. PubMed ID: 31896084
[TBL] [Abstract] [Full Text] [Related]
9. Depression induces poor prognosis associates with the down-regulation brain derived neurotrophic factor of serum in advanced small cell lung cancer.
Wu Y; Si R; Yang S; Xia S; He Z; Wang L; He Z; Wang Q; Tang H
Oncotarget; 2016 Dec; 7(52):85975-85986. PubMed ID: 27852063
[TBL] [Abstract] [Full Text] [Related]
10. Progranulin promotes Temozolomide resistance of glioblastoma by orchestrating DNA repair and tumor stemness.
Bandey I; Chiou SH; Huang AP; Tsai JC; Tu PH
Oncogene; 2015 Apr; 34(14):1853-64. PubMed ID: 24793792
[TBL] [Abstract] [Full Text] [Related]
11. miR-145 inhibits migration and invasion of glioma stem cells by targeting abcg2.
Shi L; Wang Z; Sun G; Wan Y; Guo J; Fu X
Neuromolecular Med; 2014 Jun; 16(2):517-28. PubMed ID: 24777293
[TBL] [Abstract] [Full Text] [Related]
12. Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and abcg2 in glioblastoma multiforme.
Oberstadt MC; Bien-Möller S; Weitmann K; Herzog S; Hentschel K; Rimmbach C; Vogelgesang S; Balz E; Fink M; Michael H; Zeden JP; Bruckmüller H; Werk AN; Cascorbi I; Hoffmann W; Rosskopf D; Schroeder HW; Kroemer HK
BMC Cancer; 2013 Dec; 13():617. PubMed ID: 24380367
[TBL] [Abstract] [Full Text] [Related]
13. Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma.
Suzuki T; Wada S; Eguchi H; Adachi J; Mishima K; Matsutani M; Nishikawa R; Nishiyama M
J Neurosurg; 2013 Nov; 119(5):1331-9. PubMed ID: 24010971
[TBL] [Abstract] [Full Text] [Related]
14. Breast cancer resistance protein (bcrp/abcg2): its role in multidrug resistance and regulation of its gene expression.
Nakanishi T; Ross DD
Chin J Cancer; 2012 Feb; 31(2):73-99. PubMed ID: 22098950
[TBL] [Abstract] [Full Text] [Related]
15. Impact of breast cancer resistance protein on cancer treatment outcomes.
Ross DD; Nakanishi T
Methods Mol Biol; 2010; 596():251-90. PubMed ID: 19949928
[TBL] [Abstract] [Full Text] [Related]
16. Expression of drug pathway proteins is independent of tumour type.
Zhang W; Shannon WD; Duncan J; Scheffer GL; Scheper RJ; McLeod HL
J Pathol; 2006 Jun; 209(2):213-9. PubMed ID: 16508919
[TBL] [Abstract] [Full Text] [Related]
17. Multidrug resistance transporters and modulation.
Tan B; Piwnica-Worms D; Ratner L
Curr Opin Oncol; 2000 Sep; 12(5):450-8. PubMed ID: 10975553
[TBL] [Abstract] [Full Text] [Related]
